Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Goodwill & Intangibles (2016 - 2025)

STRATA Skin Sciences' Goodwill & Intangibles history spans 15 years, with the latest figure at $4.8 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 29.08% to $4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.8 million, a 29.08% decrease, with the full-year FY2025 number at $4.8 million, down 29.08% from a year prior.
  • Goodwill & Intangibles hit $4.8 million in Q4 2025 for STRATA Skin Sciences, down from $5.7 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for SSKN hit a ceiling of $28.4 million in Q1 2022 and a floor of $4.8 million in Q4 2025.
  • Historically, Goodwill & Intangibles has averaged $16.2 million across 5 years, with a median of $14.6 million in 2021.
  • Biggest five-year swings in Goodwill & Intangibles: soared 91.75% in 2022 and later crashed 51.86% in 2025.
  • Tracing SSKN's Goodwill & Intangibles over 5 years: stood at $18.9 million in 2021, then surged by 38.71% to $26.2 million in 2022, then plummeted by 47.18% to $13.8 million in 2023, then plummeted by 51.03% to $6.8 million in 2024, then decreased by 29.08% to $4.8 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for SSKN at $4.8 million in Q4 2025, $5.7 million in Q3 2025, and $5.8 million in Q2 2025.